Douglas Adkins Selected Research

Retinoblastoma Protein

1/2016

Phase I trial of palbociclib, a selective cyclin dependent kinase 4/6 inhibitor, in combination with cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Douglas Adkins Research Topics

Disease

29	Squamous Cell Carcinoma of Head and Neck 02/2024 - 01/2013
21	Neoplasms (Cancer) 02/2024 - 02/2013
8	Head and Neck Neoplasms (Head and Neck Cancer) 03/2022 - 03/2013
4	Neutropenia 01/2019 - 01/2011
4	Sarcoma (Soft Tissue Sarcoma) 07/2016 - 01/2011
3	Carcinoma (Carcinomatosis) 02/2024 - 01/2018
3	Disease Progression 01/2021 - 01/2019
3	Oropharyngeal Neoplasms 05/2019 - 01/2017
3	Stomatitis 01/2018 - 12/2016
3	Graft vs Host Disease (Graft-Versus-Host Disease) 07/2009 - 01/2006
2	medullary Thyroid cancer 01/2024 - 01/2021
2	Thyroid Neoplasms (Thyroid Cancer) 01/2024 - 01/2021
2	Fatigue 01/2020 - 01/2018
2	Lymphopenia (Lymphocytopenia) 05/2019 - 11/2018
2	Squamous Cell Neoplasms (Squamous Cell Cancer) 11/2018 - 04/2015
2	Nausea 01/2018 - 07/2016
2	Vomiting 01/2018 - 07/2016
2	Infections 01/2018 - 09/2017
2	Mucositis 07/2016 - 06/2003
2	Febrile Neutropenia 07/2016 - 03/2013
1	Salivary Gland Neoplasms (Salivary Gland Cancer) 12/2022
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021
1	Extranodal Extension 01/2021
1	Leukopenia 01/2020
1	Nasopharyngeal Carcinoma 01/2018
1	Paresthesia (Dysesthesia) 01/2018
1	Proteinuria 01/2018
1	Colorectal Neoplasms (Colorectal Cancer) 05/2017
1	Inflammation (Inflammations) 12/2016
1	Bacterial Infections (Bacterial Infection) 12/2016

Drug/Important Bio-Agent (IBA)

16	Cetuximab (Erbitux)FDA Link 09/2022 - 01/2013
7	Cisplatin (Platino)FDA LinkGeneric 03/2021 - 01/2013
6	130-nm albumin-bound paclitaxelIBA 03/2021 - 02/2013
5	PlatinumIBA 09/2022 - 01/2016
5	Biomarkers (Surrogate Marker)IBA 09/2022 - 10/2014
5	Docetaxel (Taxotere)FDA Link 02/2017 - 03/2013
4	palbociclibIBA 09/2022 - 01/2016
3	pembrolizumabIBA 02/2024 - 01/2021
3	vandetanib (ZD6474)IBA 01/2024 - 08/2013
3	Cyclin-Dependent Kinase 4IBA 09/2022 - 01/2016
3	temsirolimus FDA Link 01/2020 - 08/2011
3	Monoclonal AntibodiesIBA 10/2016 - 09/2014
3	Fluorouracil (Carac)FDA LinkGeneric 10/2016 - 02/2013
2	RNA (Ribonucleic Acid)IBA 02/2024 - 03/2021
2	AntigensIBA 02/2024 - 09/2017
2	cabozantinibIBA 01/2024 - 01/2021
2	pralsetinibIBA 01/2024 - 01/2021
2	ErbB Receptors (EGF Receptor)IBA 12/2022 - 10/2016
2	Phosphotransferases (Kinase)IBA 10/2022 - 04/2015
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 02/2017
2	Albumin-Bound Paclitaxel FDA Link 01/2021 - 02/2017
2	Cyclin D1IBA 01/2019 - 01/2016
2	dusquetideIBA 09/2017 - 12/2016
2	Panitumumab (Vectibix)FDA Link 10/2016 - 01/2016
2	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2016 - 01/2011
2	thiamine triphosphorate (TTP)IBA 01/2016 - 12/2014
2	TOR Serine-Threonine KinasesIBA 04/2015 - 08/2011
1	VaccinesIBA 02/2024
1	IodineIBA 01/2024
1	DNA (Deoxyribonucleic Acid)IBA 01/2023
1	enzalutamideIBA 12/2022
1	Androgen Receptors (Androgen Receptor)IBA 12/2022
1	sitravatinibIBA 10/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2022
1	c-Mer Tyrosine KinaseIBA 10/2022
1	Messenger RNA (mRNA)IBA 05/2022
1	Agammaglobulinaemia Tyrosine KinaseIBA 03/2022
1	acalabrutinibIBA 03/2022
1	Viral AntigensIBA 03/2022
1	Carboplatin (JM8)FDA LinkGeneric 01/2021
1	AlbuminsIBA 01/2021
1	ElectrolytesIBA 01/2020
1	Angiogenesis InhibitorsIBA 01/2018
1	avasopasem manganeseIBA 01/2018
1	pazopanib FDA Link 01/2018
1	Superoxide DismutaseIBA 01/2018
1	SuspensionsIBA 01/2018
1	entinostat (MS 275)IBA 05/2017
1	taxaneIBA 02/2017
1	Taxoids (Taxanes)IBA 02/2017
1	cremophorIBA 02/2017
1	olaratumabIBA 07/2016
1	Growth Factor ReceptorsIBA 07/2016
1	AnthracyclinesIBA 07/2016
1	Retinoblastoma ProteinIBA 01/2016
1	Cyclin-Dependent Kinase Inhibitor p16IBA 01/2016
1	PX-866IBA 04/2015
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 04/2015
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 04/2015

Therapy/Procedure

20	Therapeutics 02/2024 - 09/2014
6	Induction Chemotherapy 03/2021 - 02/2013
5	Drug Therapy (Chemotherapy) 01/2021 - 04/2013
5	Radiotherapy 05/2019 - 01/2013
3	Immunotherapy 03/2022 - 01/2017
3	Chemoradiotherapy 03/2021 - 03/2013
3	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 10/2007 - 03/2003
2	Transplantation 06/2003 - 03/2003
1	Drug Tapering 01/2024
1	Neck Dissection (Radical Neck Dissection) 10/2019
1	Aftercare (After-Treatment) 05/2019